Case Study
Testing regime enables 17.3% YOY export growth in Chinese traditional medicines



Overview

In 2004, the Singapore Government introduced the requirement that the testing of traditional Chinese medicines must be carried out by an accredited laboratory before products can be placed on the market or exported.

Before the introduction of this testing regime, the annual sales of Chinese traditional patent medicine in Singapore was about SGD 200 million, with Chinese Mainland products accounting for 67% of the market.

By 2011, the export value of Chinese traditional patent medicine in ASEAN region, represented by Singapore, reached USD 36,870,000, with a year-on-year growth of 17.3%.




Can you suggest a case study or research report to include on business benefits?